| (Values in U.S. Thousands) | Dec, 2013 | Dec, 2012 | Dec, 2011 | Dec, 2017 | Sep, 2017 |
| Sales | 470 | 530 | 0 | 0 | 0 |
| Sales Growth | -11.32% | unch | unch | unch | unch |
| Net Income | -940 | -1,650 | -2,880 | 0 | 0 |
| Net Income Growth | +43.03% | +42.71% | unch | unch | unch |
Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
BOSTON LIFE SCIENCES INC. is a development stage biotechnology company engaged in the research and development of novel therapeutic and diagnostic products to treat chronic debilitating diseases, such as cancer, central nervous system disorders and autoimmune diseases.
Fiscal Year End Date: 12/31